Participated · Seed · Mar 2026

TippingPoint Biosciences builds a novel drug discovery platform that recreates disease-specific chromatin environments to expose transient protein–protein interfaces within the epigenome that are otherwise inaccessible. The company aims to discover first-in-class, highly selective drugs that target these epigenetic interfaces while sparing healthy cells. TippingPoint’s initial therapeutic focus is on Diffuse Intrinsic Pontine Glioma (DIPG), an aggressive pediatric brainstem tumor driven by chromatin dysfunction. The company was co-founded by Laura Hsieh and chromatin biologist Geeta Narlikar and was spun out of Narlikar’s lab at UCSF. TippingPoint has raised $2.5 million in pre-seed financing including non-dilutive grants and foundation support, received several Golden Ticket awards, and has now closed a $4.5 million seed round to advance its lead program and expand its discovery platform. The platform is described as applicable to multiple disease areas including cancer, neurodegenerative diseases and developmental disorders.

Participated · Series B · Mar 2026

Nitra embeds AI agents into core business functions—payments, procurement, inventory management, scheduling, and insurance verification—giving medical practices a single system to run their back office. Its financial suite includes a Visa-powered expense card, bill pay, patient payment processing, and AI-driven accounting, while its commerce marketplace connects users to thousands of biopharma and medical-supply products through partners like McKesson and Medline. Recently the company added a voice-AI patient management module that handles appointment scheduling and insurance eligibility checks. In 2025 the platform’s annualized revenue jumped from $4 million to more than $33 million on 740 percent growth, and it surpassed $1 billion in annualized processing volume across thousands of doctors in over 700 clinics. December 2025 saw a single-day record of roughly $9 million in purchases. Management expects to serve 3,000+ clinics, top $150 million in annualized revenue, and exceed $4 billion in processing volume during 2026. Founded in 2024 by CEO Tim Hwang and President Jonathan Chen, Nitra plans to expand headcount from about 50 to over 200 and roll out new AI modules for revenue-cycle management, patient marketing, payroll, and staffing.

Participated · Seed · Dec 2025

Seoul Beauty Club, run by Faiston Corporation, delivers curated Korean skincare products to U.S. consumers through a subscription model that emphasizes personalization. The platform specifically targets women between 30 and 60 who are underserved by existing beauty distribution channels. It has already partnered with more than 300 K-beauty brands, enabling a broad product assortment. During its beta phase the company generated several million dollars in annual recurring revenue and achieved a Net Promoter Score above 50, signaling strong early customer satisfaction. Funds from the latest round will be used to scale operations and deepen its data-driven, personalized skincare offering. Management plans to leverage the new capital to expand marketing reach and further enhance its recommendation engine. As Korean beauty continues to gain traction in the U.S., the company positions itself as a key distribution and discovery platform for both consumers and brands.

Participated · Series A · Aug 2024

BIGC operates an All-in-One Digital Venue platform that supports online monetization of live entertainment and artist IP, offering ticketing, AI-enhanced live streaming, fan interaction tools, video-on-demand, global e-commerce, and fan data analytics. The company uses proprietary AI-driven streaming technology and a data engine that analyzes fan behavior across more than 200 countries. Initially focused on K-pop and Korean cultural concerts, BIGC has expanded to J-pop, global musicians, and festival IPs. Launched two years ago, the platform is available in 224 countries and has attracted over 1.1 million registered members, about 80% of whom are international (notably Japan, Greater China, and North America). Over the past year membership grew 13x, average revenue rose nearly fivefold, and the company has sustained an average quarterly growth rate of 48% for six consecutive quarters. BIGC plans to use new funding to accelerate product development, expand its global footprint, enhance services for artists and fans, and strengthen infrastructure to support larger-scale events and more complex monetization strategies. Bigk builds an all-in-one digital venue platform that delivers concerts, showcases, artist homes, voting, live streaming, VOD, commerce and analytics using proprietary video and live/SaaS technology. The company combines AI-enhanced live technology with fandom data from more than 200 countries to connect artists and fans and help entertainment and broadcast partners monetize IP. Bigk launched targeting global K-pop and K-culture fandoms and completed projects such as CJ ENM’s KCON; it has collaborated with top K-pop artists (Infinite, Taemin, Bambam, Cha Eun-woo) and leading K-drama actors. Since launch Bigk has attracted fans across 200+ countries and reports overseas revenue exceeding 60% of sales. Founded in 2021 by CEO Kim Mi-hee (former Samsung and founder of Tutoring) with CTO Kim Jeong-woo, the team leverages seven-plus years of live and SaaS experience. The company plans further international expansion and additional fundraising to support global growth.

Participated · Series A · Apr 2024

Dalpa is a B2B AI startup focused on improving AI experience (AX) by developing customized AI solutions for enterprises. The company has internally developed over 100 AI solutions for industries including e‑commerce, fashion & beauty, marketing, and content. It has worked with more than 150 companies, including large corporates such as KT Commerce, LG Uplus and CJ OliveNetworks, and startups like MyRealTrip, Enrise and MakeUs, delivering measurable productivity gains. Customers report outcomes such as a 30% increase in purchase conversion, over 70% reduction in manual work, and roughly halving outsourcing costs. Dalpa plans to launch a new SaaS offering that provides end‑to‑end AI adoption (data connection, preprocessing, training, inference, feedback and aftercare) and to build an internal AI block‑assembly tool to automate customization. The company also plans aggressive hiring to boost AI capabilities and to prepare for overseas expansion.